Jiangsu Hengrui Pharmaceuticals Co.,Ltd (SHA:600276)
China · Delayed Price · Currency is CNY 54.89
+0.71 (1.31%)
Aug 11, 2026, 2:25 PM CST
SHA:600276 Market Cap
SHA:600276 has a market cap or net worth of 357.53 billion as of August 10, 2026. Its market cap has decreased by -12.14% in one year.
Market Cap
357.53B
Enterprise Value
317.48B
Revenue
32.56B
Ranking
n/a
PE Ratio
44.38
Stock Price
54.89
ChartMarket Cap Chart
Since October 20, 2000, SHA:600276's market cap has increased from 2.58B to 357.53B, an increase of 13,776.06%. That is a compound annual growth rate of 21.05%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 11, 2026 | 357.53B | -9.66% |
| Dec 31, 2025 | 395.76B | 35.60% |
| Dec 31, 2024 | 291.86B | 1.48% |
| Dec 29, 2023 | 287.60B | 17.03% |
| Dec 30, 2022 | 245.74B | -23.94% |
| Dec 31, 2021 | 323.08B | -45.40% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Sichuan Biokin Pharmaceutical | 131.74B |
| Zhejiang NHU Company | 95.39B |
| Yunnan Baiyao Group Co.,Ltd | 91.34B |
| Shanghai Fosun Pharmaceutical (Group) | 58.55B |
| Huadong Medicine | 51.96B |
| China Resources Sanjiu Medical & Pharmaceutical | 42.05B |
| Shenzhen Salubris Pharmaceuticals | 40.18B |
| Dong-E-E-Jiao | 34.50B |